Literature DB >> 18846103

Towards preventive medicine. High-throughput methods from molecular biology are about to change daily clinical practice.

Hrvojka Bosnjak1, Kresimir Pavelic, Sandra Kraljevic Pavelic.   

Abstract

Mesh：

Year:  2008        PMID： 18846103      PMCID： PMC2581852          DOI： 10.1038/embor.2008.198

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  24 in total

Review 1.  The microenvironment of the tumour-host interface.

Authors:  L A Liotta; E C Kohn
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Characterization of renal allograft rejection by urinary proteomic analysis.

Authors:  William Clarke; Benjamin C Silverman; Zhen Zhang; Daniel W Chan; Andrew S Klein; Ernesto P Molmenti
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

Review 3.  Clinical proteomics: translating benchside promise into bedside reality.

Authors:  Emanuel F Petricoin; Kathryn C Zoon; Elise C Kohn; J Carl Barrett; Lance A Liotta
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

4.  Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction.

Authors:  L S Cohen; P F Escobar; C Scharm; B Glimco; D A Fishman
Journal:  Gynecol Oncol       Date:  2001-07       Impact factor: 5.482

Review 5.  Molecular portraits and the family tree of cancer.

Authors:  Christine H Chung; Philip S Bernard; Charles M Perou
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

6.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

7.  Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer.

Authors:  Susan M Varnum; Chandice C Covington; Ronald L Woodbury; Konstantinos Petritis; Lars J Kangas; Mohamed S Abdullah; Joel G Pounds; Richard D Smith; Richard C Zangar
Journal:  Breast Cancer Res Treat       Date:  2003-07       Impact factor: 4.872

8.  A gene-expression signature as a predictor of survival in breast cancer.

Authors:  Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

9.  The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide.

Authors:  Piotr Lewczuk; Hermann Esselmann; Markus Meyer; Volker Wollscheid; Manuela Neumann; Markus Otto; Juan Manuel Maler; Eckart Rüther; Johannes Kornhuber; Jens Wiltfang
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

Review 10.  Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein.

Authors:  Harald Hampel; Alexander Goernitz; Katharina Buerger
Journal:  Brain Res Bull       Date:  2003-08-15       Impact factor: 4.077
View more
  1 in total

1.  Managing the moral expansion of medicine.

Authors:  Bjørn Hofmann
Journal:  BMC Med Ethics       Date:  2022-09-22       Impact factor: 2.834
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.